Randomized Phase I/II Trial of LB-100 Plus Doxorubicin vs Doxorubicin Alone of Advanced Soft Tissue Sarcomas
Condition: Advanced Soft-tissue Sarcoma Interventions: Drug: LB-100 plus Doxorrubicin; Drug: Doxorubicin Sponsor: Grupo Espanol de Investigacion en Sarcomas Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials